XTX Topco’s BioAge Labs BIOA Stock Holding History

XTX Topco’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$820K	Buy	46,878 +10,151	+28%	+$195K	0.01%	1595
2025 Q4	$486K	Buy	+36,727	New	+$326K	0.01%	1627

Other funds holding BIOA

ACM

AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

XTX Topco's BIOA Position: Q1 2026 in Review

XTX Topco increased its BioAge Labs (BIOA) stake by 28% in Q1 2026, buying an estimated $195K and bringing the position to 46,878 shares worth $820K. The position accounts for 0.01% of the portfolio, ranked #1595.

XTX Topco first reported a position in BIOA in Q4 2025 and has held it in 2 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

XTX Topco held 46,878 shares of BioAge Labs worth $820K as of Q1 2026.
XTX Topco bought 10,151 BioAge Labs shares in Q1 2026, an estimated $195K.
BioAge Labs made up 0.01% of XTX Topco's portfolio in Q1 2026, its #1595 holding.
XTX Topco first reported a position in BioAge Labs in Q4 2025 and has held it in 2 quarters since.
144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.